| Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials J Savović, HE Jones, DG Altman, RJ Harris, P Jüni, J Pildal, B Als-Nielsen, ... Annals of internal medicine 157 (6), 429-438, 2012 | 1302 | 2012 |
| Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials J Pildal, A Hrobjartsson, KJ Jørgensen, J Hilden, DG Altman, ... International journal of epidemiology 36 (4), 847-857, 2007 | 532 | 2007 |
| Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study J Pildal, AW Chan, A Hróbjartsson, E Forfang, DG Altman, PC Gøtzsche Bmj 330 (7499), 1049, 2005 | 235 | 2005 |
| Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review J Pildal, PC Gøtzsche Clinical infectious diseases 39 (1), 38-46, 2004 | 168 | 2004 |
| Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory A Hróbjartsson, J Pildal, AW Chan, MT Haahr, DG Altman, PC Gøtzsche Journal of clinical epidemiology 62 (9), 967-973, 2009 | 72 | 2009 |
| Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus AM Møller, NM Jensen, J Pildal, T Drivsholm, K Borch-Johnsen, ... The Journal of Clinical Endocrinology & Metabolism 86 (5), 2181-2186, 2001 | 35 | 2001 |
| Development of a combined database for meta‐epidemiological research J Savović, RJ Harris, L Wood, R Beynon, D Altman, B Als‐Nielsen, ... Research synthesis methods 1 (3‐4), 212-225, 2010 | 24 | 2010 |
| Leukocytoclastic vasculitis induced by subcutaneous injection of human insulin in a patient with type 1 diabetes and essential thrombocytemia T Mandrup-Poulsen, J Molvig, J Pildal, AK Rasmussen Diabetes Care 25 (1), 242, 2002 | 20 | 2002 |
| Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes J Pildal, M Lajer, SK Hansen, K Almind, L Ambye, K Borch‐Johnsen, ... Diabetic medicine 20 (6), 491-494, 2003 | 15 | 2003 |
| Peptide hormone processing in tumours: biogenetic and diagnostic implications JF Rehfeld, L Bardram, S Blanke, JR Bundgaard, L Friis-Hansen, ... Tumor biology 14 (3), 174-183, 1993 | 14 | 1993 |
| Somatostatin in the boar reproductive system L Ødum, J Pildal, JF Rehfeld European journal of endocrinology 130 (5), 515-521, 1994 | 8 | 1994 |
| Systemic and local allergy to human insulin M Wittrup, J Pildal, AK Rasmussen, BG Skov, J Petersen, ... Ugeskrift for Laeger 165 (21), 2207-2208, 2003 | 4 | 2003 |
| Systemisk og lokal allergi over for humant insulin M Wittrup, J Pildal, AK Rasmussen, BG Skov, J Petersen, ... Ugeskrift for Læger 165 (21), 2207-2208, 2003 | 1 | 2003 |
| Kommentar: Kritikken er berettiget J Pildal, PC Gotzsche LAKARTIDNINGEN, 5625-5625, 2001 | 1 | 2001 |
| National Klinisk Retningslinje (NKR) for Tidlig Opsporing og Behandling af Non-alkoholisk fedtleversygdom og Non-alkoholisk steatohepatitis S Heebøll, J Pildal, LL Gluud, H Grønbæk, JM Bruun, VB Christensen, ... | | 2019 |
| Erratum: Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials (International Journal of Epidemiology)(2007) vol. 36 (847-857) J Pildal, A Hróbjartsson, KJ Jørgensen, J Hilden, DG Altman, ... International Journal of Epidemiology 37 (2), 422, 2008 | | 2008 |
| Protection against bias in randomised clinical trials and meta-analyses J Pildal UGESKRIFT FOR LAEGER 167 (35), 3317, 2005 | | 2005 |
| No association of the Hph1 insulin gene polymorphism to type 2 diabetes or insulin secretion in Danish Caucasians. J Pildal, SK Rasmussen, SA Urhammer, T Hansen, CT Ekstrom, ... DIABETOLOGIA 43, A84-A84, 2000 | | 2000 |
| National klinisk retningslinje for tidlig opsporing og behandling af non-alkoholisk fedtleversygdom og non-alkoholisk steatohepatitis J Pildal | | |
